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Background: Human induced pluripotent stem cells (hiPSCs) play roles in both disease modelling and regenerative
medicine. It is critical that the genomic integrity of the cells remains intact and that the DNA repair systems are
fully functional. In this article, we focused on the detection of DNA double-strand breaks (DSBs) by phosphorylated
histone H2AX (known as γH2AX) and p53-binding protein 1 (53BP1) in three distinct lines of hiPSCs, their source
cells, and one line of human embryonic stem cells (hESCs).
Methods: We measured spontaneously occurring DSBs throughout the process of fibroblast reprogramming and
during long-term in vitro culturing. To assess the variations in the functionality of the DNA repair system among
the samples, the number of DSBs induced by γ-irradiation and the decrease over time was analysed. The foci
number was detected by fluorescence microscopy separately for the G1 and S/G2 cell cycle phases.
Results: We demonstrated that fibroblasts contained a low number of non-replication-related DSBs, while this
number increased after reprogramming into hiPSCs and then decreased again after long-term in vitro passaging.
The artificial induction of DSBs revealed that the repair mechanisms function well in the source cells and hiPSCs
at low passages, but fail to recognize a substantial proportion of DSBs at high passages.
Conclusions: Our observations suggest that cellular reprogramming increases the DSB number but that the repair
mechanism functions well. However, after prolonged in vitro culturing of hiPSCs, the repair capacity decreases.
Keywords: Human induced pluripotent stem cells, DNA double-strand breaks, γH2AX, 53BP1, Long-term in vitro
culture, DNA repairBackground
Human induced pluripotent stem cells (hiPSCs) hold
great promise for clinical applications because of their
potential to differentiate into all three embryonic germ
layers [1–3]. To use hiPSCs in cell therapy or disease
modelling [4], it is fundamental that they possess an
intact genome. Much research has been performed in
the field of genome maintenance in mouse and human
embryonic stem cells (hESCs). However, less is known* Correspondence: p.simara@mail.muni.cz
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tionality of repair mechanisms in hiPSCs [5]. In general,
the genomic instabilities in hiPSCs may be introduced:
1) by pre-existing mutations in source cells; 2) during
reprogramming; and 3) during in vitro expansion of the
hiPSCs. It has been reported that at least 50% of the
single-nucleotide variations in hiPSCs pre-existed in the
source cells [6]. The process of reprogramming itself rep-
resents a serious risk of mutation acquisition. Primarily,
deletions of tumour suppressor genes were observed dur-
ing reprogramming [7]. Using episomal vectors may lower
the risk of reprogramming-associated genome changes
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omic instabilities, resulting from the adaptation to cul-
ture conditions and clonal selection during passaging.
The data reported by Taapken et al. [9] support this
idea, indicating that the types and frequency of karyo-
typic abnormalities are similar between hESCs and
hiPSCs. In contrast, the results of Laurent et al. [7]
revealed slight differences in the distribution of sub-
chromosomal variations between hESCs and hiPSCs.
Interestingly, in their study [7], prolonged in vitro cul-
turing was associated with oncogene duplication.
One of the key techniques for monitoring DNA integ-
rity is the detection of DNA double-strand breaks
(DSBs). DSBs are a severe type of DNA damage that
may cause irreversible changes in the genomic content
of the cell. They are induced by internal factors such as
the by-products of cell metabolism or replication stress,
or by external factors such as exposure to irradiation or
chemical agents [10]. A damaged cell may arrest the
cell cycle until the lesions are repaired. If the DNA
damage is not successfully repaired, apoptosis is com-
monly induced to prevent the propagation of chromo-
somal aberrations. The repair of DSBs is executed
either by fast non-homologous end-joining (NHEJ) or
more precise homologous recombination (HR). Both
mechanisms contribute to DSB repair in a cell cycle-
specific manner. NHEJ occurs at all phases of the cell
cycle but is primarily responsible for DSB repair in the
G1 stage. HR occurs predominantly in the late S and
G2 phases [11]. Published data suggest that pluripotent
cells exert stronger genomic protection and can repair
DNA lesions more efficiently than differentiated som-
atic cells [5, 12–14]. However, a strong DNA protective
mechanism may cause the pluripotent cells to be more
prone to apoptosis.
Various DNA damage-response proteins have been
used as markers of DSBs, including phosphorylated
histone H2AX (known as γH2AX) and p53-binding
protein 1 (53BP1) [15]. The generation of γH2AX foci
at the site of DNA lesions precedes the formation of
53BP1 foci [16–18]. Several studies have confirmed that
53BP1 functions exclusively in NHEJ and that it inhibits
the 5′ end resection needed for HR [19–21]. In con-
trast, γH2AX influences both NHEJ and HR [10]. The
foci formation of γH2AX is dependent on the cell cycle
phase [22–24]. S/G2 phase cells exhibit more γH2AX
foci than do cells in G1 phase because of replication-
related DSBs. Cell-cycle dependency has not been ob-
served for 53BP1 [25].
In the present study, we compared the genomic integ-
rity of fibroblasts and pluripotent stem cells. We used
fluorescence microscopy to visualize the DSBs recog-
nized by γH2AX and 53BP1 in three hiPSC lines and
one hESC line at low or high passage numbers and inone line of source cell fibroblasts. Each hiPSC line is
unique and represents a different reprogramming ap-
proach, as described in the Methods. We also aimed to
detect differences in the ability to recognize DSBs artifi-
cially induced by γ-irradiation and their decrease over
time. The measurements were conducted with respect
to cell cycle stage, and the data were analysed separately
for the G1 and G2/S phases. Thus, we aimed to eluci-
date genomic stability during hiPSC generation and
in vitro culturing.
Methods
hiPSC generation and cell culture
Human dermal fibroblasts (hDFs; kindly provided by
the National Tissue Centre Inc., Brno, Czech Repub-
lic) and CD34+ haematopoietic progenitors (blood
sample kindly provided by the Department of Internal
Medicine, Haematology and Oncology, Masaryk Uni-
versity, and University Hospital Brno, Czech Republic)
were used as source cells for the generation of hiPSCs
as described in Šimara et al., 2014 [26, 27]. For this
study, we used the hiPSC line CBIA-3–CD34+ haem-
atopoietic progenitors reprogrammed by the Sendai
virus (CytoTuneTM-iPS Reprogramming Kit; Thermo
Fisher Scientific, Waltham, MA, USA), hiPSC line
CBIA-5–fibroblasts reprogrammed by the Sendai
virus, and hiPSC line CBIA-7–fibroblasts repro-
grammed by episomal vectors (Epi5™ Episomal iPSC
Reprogramming Kit; Thermo Fisher Scientific). The
CCTL-14 hESC line [28] was a kind gift from the
Department of Histology and Embryology (Faculty of
Medicine, Masaryk University, Brno, Czech Republic).
All three hiPSC lines and the hESC line were main-
tained in the form of colonies on irradiated mouse
embryonic fibroblast feeder cells (MEFs; 2.5 × 105 cells
per 3.5-cm dish) in DMEM/F12 (1:1) supplemented
with 20% knock-out serum replacement, 2 mM L-glutam-
ine, 100 μM non-essential amino acids, 1% penicillin/
streptomycin, 0.1 mM 2-mercaptoethanol, and 10 ng/ml
basic fibroblast growth factor (bFGF) (all from
Thermo Fisher Scientific). The medium was changed
daily. Markers of pluripotency (Oct-3/4, Sox2, Nanog,
and SSEA4) were detected as described previously
[26], and all three hiPSC lines were positive for all of
these markers (Additional file 1: Figure S1). A teratoma
formation assay confirmed that the hiPSCs could dif-
ferentiate into all three germ layers (Additional file 2:
Figure S2).
The following cell passage numbers (p) were used
(low and high): CBIA-3 at p27 and p76, CBIA-5 at p19
and p65, CBIA-7 at p25 and p67, and CCTL-14 at p30
and p302. hDFs were used at p6. No CD34+ blood
progenitors used to generate CBIA-3 were available for
DSB analysis.
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Prior to irradiation, the hiPSCs and hESCs were feeder
depleted by culturing on a Geltrex® matrix for 3 days.
Essential 8™ medium (Thermo Fisher Scientific) was
changed daily. The cells were then irradiated by ionizing
radiation (IR; 0.5 Gy/min; 137Cs; 1 and 4 Gy) to induce
DSBs and fixed in 4% paraformaldehyde at 0.5, 2, and
6 h after irradiation.
The dose of 1 Gy was selected for the experiments
based on published results [12, 29] and our DSB count
measurement after 1 Gy or 4 Gy irradiation (data not
shown). The peak value of the foci number was recorded
0.5 h after irradiation; therefore, this time point was
selected for the study of the functionality of the repair
system.
Immunocytochemistry
Immunocytochemical staining was used to visualize the
DSBs and distinguish between the cell cycle stages G1
and S/G2. Four hours before fixation, a nucleoside
analogue of thymidine, 5-ethynyl-2′-deoxyuridine (EdU;
Thermo Fisher Scientific), was added at a final concentra-
tion of 10 μM. The cells were fixed in 4% paraformalde-
hyde and permeabilized in 0.2% Triton-X (both from
Sigma-Aldrich, St. Louis, MO, USA). Overnight incuba-
tion with primary antibodies against γH2AX (Biolegend,
San Diego, CA, USA) and 53BP1 (Santa Cruz Biotechnol-
ogy, Dallas, TX, USA) was followed by 1 h of incubation
with a secondary antibody conjugated with Alexa 555
(Cell Signaling Technology, Danvers, MA, USA). The
samples were stained with the Click-iT® EdU Alexa Fluor®
488 Imaging Kit (Thermo Fisher Scientific) to visualize
EdU according to the manufacturer’s instructions. Finally,
the nuclei were stained with Hoechst dye (BisBenzemide
H33342; 1 μg/ml; Sigma-Aldrich).
Fluorescence microscopy and image analysis
Fluorescent signals were detected using the Zeiss Axio-
vert 200 M system (Carl Zeiss, Oberkochen, Germany).
The images were captured using a CoolSNAP HQ2
CCD camera in the wide-field mode (Photometrics,
Tucson, AZ) at –30 °C. Thirty 3-μm slices were acquired
in each field at a resolution of 1392 × 1040 pixels. The
pixel size of the images was 124 × 124 nm. Between 500
and 1000 cells were analysed from each microscopic
slide. Two slides, γH2AX and 53BP1, were prepared
from each sample and each time point.
Acquiarium software, developed by our group, was
used to acquire and analyse the images [30]. Acquiarium
is open source software available for download at our
group’s official website (http://cbia.fi.muni.cz/projects/
acquiarium.html). During the analysis, individual cells in
the field of view were first cropped manually. Next, the
nucleus of each cell, stained with Hoechst dye, wasrecognized automatically using the “Find objects (hyster-
esis thresholding)” plugin. We used the Gaussian filter
in the preprocessing phase (with sigma = 1), the thresh-
old was calculated using the two-level Otsu method, and
we defined the minimum size of an object to exclude the
parts of adjacent cells. This plugin defined the area in
which we counted γH2AX or 53BP1 foci. For this
purpose, we employed the eMax algorithm described in
[31] using the parameters sigma = 1, a spot height
threshold of 80, and a maximum spot size of 800, which
we set empirically. The EdU signal was quantified based
on the total intensity calculated in the nucleus. The
threshold for the separation of EdU-negative (G1) and
EdU-positive (S/G2) cells was computed in MATLAB
(Mathworks) using the Otsu method.Flow cytometry analysis
To assess early apoptosis, cells were stained with
Annexin-V fluorescein isothiocyanate (FITC) and 7-
amino-actinomycin D (7-AAD; BD Via-Probe) in
Annexin-V binding buffer (Miltenyi Biotec, Bergisch
Gladbach, Germany). From each sample, approximately
1 × 105 cells were processed. All of the samples were
measured using a BD FACS Canto II flow cytometer
(Becton-Dickinson). BD FACSDiva (Becton-Dickinson)
software was used for the data analysis.Western blotting
For each time point, approximately 1 × 106 cells were
lysed in RIPA buffer. The total protein concentration
was assessed using a Pierce™ BCA Protein Assay Kit
(Thermo Fisher Scientific). Laemmli buffer was added,
and the samples were separated by SDS-PAGE. The pro-
teins were transferred onto polyvinylidene fluoride
membranes, and the membranes were blocked with 5%
milk in TBS-Tween for 1 h. The membranes were then
incubated with a 1:1000 dilution of PARP and GAPDH
primary antibodies (both from Cell Signaling Technol-
ogy) in TBS-Tween with 5% milk at 4 °C overnight.
Subsequently, the membranes were incubated with the
secondary antibody (1:5000 anti-rabbit HRP; Cell Signal-
ing Technology) for 1 h at room temperature, and the
blots were developed using the Clarity™ Western ECL
Substrate (Bio-Rad Laboratories, Hercules, CA, USA)
according to the manufacturer’s instructions.Statistical analysis
Comparison of two data sets was performed using
Student’s t test. Multi-group assays were analysed by a
one-way analysis of variance (ANOVA) in conjunction
with Tukey’s test. A level of P ˂ 0.05 was considered to
be statistically significant.
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Discrimination between the cell cycle phases using EdU
increases the accuracy of analysing DNA lesions
The overall goal of our study was to use the numbers
of γH2AX and 53BP1 foci as a measure of DNA repair
in hiPSCs and in their somatic founders. However, as
described above, it has been previously shown that the
numbers of γH2AX foci are influenced by the cell cycle
phase, with more foci being present in the S/G2 nuclei
than in the G1 nuclei [22–24]. Obviously, different
types of cells (somatic versus pluripotent) as well as
cells in different states of culture (early versus late)
most likely differ in the lengths of the individual phases
of their cell cycle. Therefore, we first determined to
what extent the numbers of foci are influenced by cell
cycle speed and may thus distort the overall picture ob-
tained by the foci analysis. To do so, we labelled newly
synthesized DNA with EdU, visualized the accumula-
tion of γH2AX and 53BP1 proteins on chromatin (foci),
and then used an automated analysis. This approach is
shown in Fig. 1a. Figure 1b and c exemplify the situ-
ation when an EdU-positive cell (nucleus) contains a
larger number of γH2AX foci compared to EdU-
negative cells (nuclei). Before we counted the numbers
of γH2AX and 53BP1 foci, we analysed the EdU signal
distribution among the cell samples and separated the
EdU-negative (G1 phase) and EdU-positive (S/G2 phase)a
b c
Fig. 1 Image analysis in three dimensions using Acquiarium software. a Au
border line and counting of 21 γH2AX foci (red) inside the cell nucleus, visu
incorporated during DNA synthesis. b A significantly higher count of γH2A
in the adjacent cells. c The cell in the middle is strongly positive for EdU (g
γH2AX foci result from replication stress. The hiPSC line CBIA-5 at low passa
Scale bar = 5 μm. EdU 5-ethynyl-2′-deoxyuridinenuclei. The EdU signal strength in particular cells in each
sample was then expressed as a histogram (with a calcu-
lated threshold for EdU negativity) for maximum clar-
ity and reproducibility in separating G1 and S/G2
cells. Histograms of all analysed samples are shown in
Additional file 3 (Figure S3). Our data revealed a sta-
tistically significant difference in cell cycle phase dis-
tribution between hDFs, representing a somatic cell
type, and all pluripotent stem cells, irrespective of
their type and passage number (Fig. 2). The high pro-
portion (87.2%) of EdU-negative cells in the hDF
sample suggests that the vast majority of these cells
remain in G1 phase. By contrast, only between 49.5
and 57.0% of the pluripotent cells were EdU negative,
confirming their high proliferation activity and short
cell cycle.
Taken together, this series of experiments demon-
strates the robustness of the approach that we have de-
veloped to visually discriminate between G1 and S/G2
cells in situ. Our data show that, using this technique,
we can identify changes in cell cycle progression. In the
context of cell cycle-associated differences in numbers of
γH2AX and 53BP1 foci, this approach is extremely use-
ful and was employed for all the following analyses in
this study. The Acquiarium software also represents an
extremely valuable tool for complex and automated
microscope image analysis.tomatic detection of the cell nucleus (blue) marked with a yellow
alized by yellow dots. The green regions emerge as EdU is newly
X foci is seen in the nucleus of the cell in the middle of the field than
reen), suggesting that the cell passes through the S or G2 phase, and
ge, non-irradiated control, γH2AX. A merge of 30 3-μm slices is shown.
Fig. 2 Distribution of EdU-negative cells in the samples. Comparison of fibroblasts (hDF), hiPSCs (CBIA-3, CBIA-5, and CBIA-7), and hESCs (CCTL-14)
at low or high passage number. The mean value of the percentage of EdU-negative cells calculated from six histograms is shown (± SEM). A
massive disproportion in the EdU-negative cell group was observed between hDF somatic cells and pluripotent stem cells. *P ˂ 0.05 by one-way
ANOVA and Tukey’s multiple comparison test. EdU 5-ethynyl-2′-deoxyuridine, hDF human dermal fibroblast
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γH2AX and 53BP1 foci, but this trend is reversed with
prolonged in vitro culturing
First, we wanted to determine whether reprogramming to
pluripotency influences the numbers of DSBs as revealed
by the presence of γH2AX and 53BP1 foci. To do so, we
counted these foci in the parent fibroblasts (hDFs) and in




Fig. 3 DSBs recognized by γH2AX (a,c) and p53-binding protein 1 (53BP1)
with 1 Gy (c,d). Comparison of fibroblasts (human dermal fibroblast; hDF), h
passage number. The number of foci in each cell is visualized as a dot, and
are shown in the EdU-negative population. *P ˂ 0.05 between hDF and iPS
ANOVA and Tukey’s multiple comparison testand CBIA-7) at an early stage after their establishment (up
to passage 27; further referred to as low-passage hiPSCs).
As shown in Fig. 3a and b, the numbers of both types of
foci in EdU-negative hiPSCs were higher than those
observed in EdU-negative hDFs. Specifically, in hDFs, the
average number of foci per cell was only 1.1 for γH2AX
and 1.5 for 53BP1. In hiPSCs, however, these numbers
ranged from 5.6 to 5.9 for γH2AX and from 2.1 to 4.0(b,d) in non-irradiated control cells (Ctrl) (a,b) or 0.5 h after γ-irradiation
iPSCs (CBIA-3, CBIA-5, and CBIA-7) and hESCs (CCTL-14) at low or high
the mean value is shown as a black line for each sample. The results
Cs in low passage, and between low and high passages, by one-way
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CBIA-7 cells produced about the same numbers of
γH2AX foci (5.69 and 5.89, respectively) despite the dif-
ferent reprogramming method used to generate these
cells (Sendai virus versus episomal vectors). The next
question was whether prolonged passaging of hiPSCs
may further affect the number of DSBs. To obtain this
information, we evaluated foci in hiPSCs (all three lines
as above) that were cultured for a minimum of 65
passages (further referred to as high-passage cells). In
these high-passage hiPSCs, the numbers of foci de-
creased (compared to low-passage cells), reaching levels
of only 2.6 to 4.4 foci per cell for γH2AX and 1.5 to 1.6
foci per cell for 53BP1.
As described in the previous section, EdU-positive
(S/G2) cells are characterized by many more DSBs than
EdU-negative (G1 phase) cells, possibly as a result of
replicative stress-associated amplification of DNA lesions
during the progression of the cell cycle. Accordingly, the
numbers of both γH2AX and 53BP1 foci were increased
in EdU-positive cells compared to EdU-negative cells in
all cell lines and passage categories (low and high) ana-
lysed in this experiment (Fig. 4). Interestingly, this S/
G2-linked increase was the highest in hDFs, with the
mean numbers of foci per EdU-positive cell being 29.9
for γH2AX and 19.6 for 53BP1, probably reflecting
their highly effective “healthy” repair machinery. In the
low-passage hiPSCs, the respective mean numbers were
slightly lower than in hDFs, 23.0–25.1 for γH2AX and
8.8–15.3 for 53BP1, while in high-passage hiPSCs these
numbers dropped down to 11.0–17.9 for γH2AX and
4.7–6.5 for 53BP1. It is also of note that the mean num-
bers of γH2AX foci were always (in all cell lines as well
as passage categories) higher than those of 53BP1 foci
(Fig. 4a).
Since we hypothesized that increased DSBs are due to
reprogramming rather than being associated with pluri-
potency, we thought that hESCs would have a rather low
basal level of DSBs, possibly about the same as in hDFs.
To address this issue, we also analysed a reference line
of hESCs (CCTL-14) that we have shown in our previ-
ous work to conform in all aspects to hESC standards
[28]. Contrary to our expectation, the numbers of DSB-
associated foci in new, low-passage hESCs were much
closer to those in hiPSCs than in hDFs. This held true
for both EdU-negative and EdU-positive cells. Specific-
ally, in EdU-negative cells the numbers averaged 4.5 for
γH2AX and 2.7 for 53BP1 foci, and in EdU-positive cells
they averaged 12.8 for γH2AX and 10.3 for 53BP1 foci.
Clearly, the numbers of foci in hESCs follow the same
trend as in hDFs and hiPSCs, being dramatically in-
creased in S/G2 cells compared to the cells in G1 phase.
Additionally, as in hDFs and hiPSCs, the numbers of
γH2AX foci in hESCs were always higher than those of53BP1 foci. Surprisingly, however, in hESCs the numbers
of γH2AX- and 53BP1-associated foci further increased
with their prolonged culturing, which was in strict
contrast to what we observed in hiPSCs (see above).
Specifically, the numbers of foci per cell in high-passage
hESCs were as follows: in the EdU-negative cells, 6.7 for
γH2AX and 4.8 for 53BP1 foci; in the EdU-positive cells,
19.3 for γH2AX and 14.3 for 53BP1 foci. The complete
set of foci numbers is shown in Table 1.
hiPSCs lose their DNA repair capacity after prolonged
maintenance in vitro
The above experiments demonstrated that, under nor-
mal culture conditions, hDFs, hiPSCs, and hESCs all
have characteristic numbers of γH2AX and 53BP1 foci.
However, based on these measurements we cannot
resolve whether this is due to differences in the level of
“spontaneous” DNA damage, DNA repair capability
(recognition of DNA lesions), or both. It is understood
that the amount of DSBs in cultured cells caused by γ-
irradiation is about the same for the same dose of
irradiation, regardless of the type of cell. With this
holding true, the numbers of γH2AX and 53BP1 foci
detected in cells irradiated by the same dose of γ-rays
should then reflect the capability of the DNA repair
machinery to recognize DSBs rather than the level of
DNA damage. In the following series of experiments,
we built on this presumption to study the DNA repair
efficiency of human pluripotent stem cells. We irradi-
ated the respective cells (hDFs, hiPSCs, and hESCs)
with the same dose of γ-rays (1 Gy) and then deter-
mined the number of γH2AX and 53BP1 foci at three
different time points after irradiation (0.5, 2, and 6 h).
It has previously been shown that the levels of γH2AX
and 53BP1 loaded onto chromatin usually reach a max-
imum at approximately 15–30 min after ionizing irradi-
ation [32–34]. Based on this data, we used 30 min as
the starting point. Two additional time points (2 and
6 h) then provided information on how DNA repair is
sustained.
Figure 3c and d show the numbers of γH2AX and
53BP1 foci 30 min after γ-irradiation in EdU-negative
cells. As expected for normal cells, hDFs exhibited a
dramatic increase to 19.9 and 15.6, respectively. This
represents an 18-fold (for γH2AX) and 10-fold (for
53BP1) increase over their numbers in non-irradiated
controls, which indeed mirrors a massive initiation of
DNA repair pathways (Fig. 4b). Surprisingly, although
the numbers of both types of foci were higher in non-
irradiated hiPSCs (irrespective of their passage number)
than in hDFs (see the previous section), this was not the
case for irradiated hiPSCs. Specifically, at 30 min after ir-
radiation, low-passage hiPSCs produced 21.9 to 28.6
γH2AX foci and 17.8 to 20.1 53BP1 foci, thus always
ab
Fig. 4 Cell cycle-dependent changes in the γH2AX and p53-binding protein 1 (53BP1) foci number. A comparison of the foci number between
the G1 phase (Edu negative; black column) and S/G2 phase (EdU positive; grey column) was performed in one fibroblast line (human dermal fibroblast;
hDF), three hiPSC lines (CBIA-3, CBIA-5, and CBIA-7) and one hESC line (CCTL-14) at high or low passage number. a The number of foci per cell is
shown in non-irradiated control cells (Ctrl) and irradiated cells (1 Gy; 0.5 h after irradiation). b Percentage of increase in γH2AX and 53BP1 foci after
1 Gy treatment. The mean ± SEM is shown. *P ˂ 0.05 by t test
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In contrast, high-passage hiPSCs produced only 8.0 to
12.4 γH2AX foci and 8.0 to 16.9 53BP1 foci. In other
words, in hiPSCs, their prolonged passaging dramatically
diminished the numbers γH2AX and 53BP1 foci induced
by γ-rays to levels below or similar to those observed in
hDFs.
As described in the previous section, the numbers of
“spontaneous” γH2AX and 53BP1 foci were, for all cell
types and categories studied here, always higher in S/G2
(EdU-positive) then in G1 (EdU-negative) cells. In hiPSCs,the fold-increase ranged from three-times in high-passage
CBIA-5 cells (53BP1) to 4.6-times in high-passage CBIA-7
cells (γH2AX), and the changes were consistently statisti-
cally significant (Fig. 4a). This overall trend was also
retained in γ-irradiated cells (at 30 min after irradiation);
however, the actual fold-increase (S/G2 versus G1) was
much lower, in four cases showing either no changes or
statistically insignificant changes (for both γH2AX and
53BP1 foci in high-passage CBIA-3 and CBIA-7 hiPSCs)
(Fig. 4a). Specifically, for hiPSCs, the fold-increase ranged
from none to 2.1-times (24.6/11.6) for γH2AX foci in
Table 1 Number of foci per cell
Non-irradiated control cells Irradiated cells (1Gy)
G1 (EdU-negative cells) S/G2 (EdU-positive cells) G1 (EdU-negative cells) S/G2 (EdU-positive cells)
No. of foci ± SEM No. of cells No. of foci ± SEM No. of cells No. of foci ± SEM No. of cells No. of foci ± SEM No. of cells
hDF
γH2AX 1.13 ± 0.11 463 29.9 ± 1.32 60 19.89 ± 0.36 485 45.49 ± 0.88 97
53BP1 1.49 ± 0.07 486 19.64 ± 1.23 80 15.55 ± 0.22 501 19.20 ± 0.91 69
CBIA-3 low
γH2AX 5.56 ± 0.22 464 22.98 ± 0.38 523 21.87 ± 0.34 612 28.71 ± 0.34 554
53BP1 2.13 ± 0.12 445 8.76 ± 0.35 407 19.01 ± 0.31 552 23.1 ± 0.42 496
CBIA-3 high
γH2AX 4.42 ± 0.20 483 17.91 ± 0.41 337 8.01 ± 0.27 594 7.97 ± 0.35 480
53BP1 1.46 ± 0.07 625 4.73 ± 0.18 510 14.45 ± 0.29 551 13.66 ± 0.31 447
CBIA-5 low
γH2AX 5.69 ± 0.23 542 25.1 ± 0.47 415 28.6 ± 0.52 437 41.00 ± 0.55 421
53BP1 4.03 ± 0.18 445 15.3 ± 0.49 425 17.84 ± 0.26 613 23.32 ± 0.30 642
CBIA-5 high
γH2AX 2.98 ± 0.13 520 10.98 ± 0.26 508 11.57 ± 0.27 445 24.45 ± 0.39 480
53BP1 1.56 ± 0.07 608 4.71 ± 0.21 461 8.04 ± 0.17 490 10.84 ± 0.20 514
CBIA-7 low
γH2AX 5.89 ± 0.25 382 23.77 ± 0.45 414 26.48 ± 0.44 511 36.71 ± 0.52 444
53BP1 2.73 ± 0.13 487 10.42 ± 0.31 421 20.05 ± 0.35 591 21.94 ± 0.38 560
CBIA-7 high
γH2AX 2.56 ± 0.13 547 11.78 ± 0.25 534 12.41 ± 0.26 580 12.73 ± 0.30 452
53BP1 1.51 ± 0.07 586 6.5 ± 0.27 415 16.9 ± 0.32 556 17.62 ± 0.34 415
CCTL-14 low
γH2AX 4.45 ± 0.20 554 12.83 ± 0.31 544 20.99 ± 0.34 634 30.37 ± 0.57 378
53BP1 2.73 ± 0.14 629 10.28 ± 0.36 508 16.77 ± 0.27 681 19.13 ± 0.39 452
CCTL-14 high
γH2AX 6.66 ± 0.29 510 19.30 ± 0.49 427 16.26 ± 0.28 642 19.38 ± 0.34 423
53BP1 4.75 ± 0.21 576 14.34 ± 0.52 402 21.49 ± 0.30 653 24.20 ± 0.42 425
The number of foci per cell and the number of analysed cells are shown for non-irradiated control cells and cells 0.5 h after irradiation with 1 Gy. Five samples
were analysed: a fibroblast line (hDF), three hiPSC lines (CBIA-3, CBIA-5, and CBIA-7) and one hESC line (CCTL-14) at high or low passage number. The values are
shown for the separated cell cycle phases G1 (EdU-negative) or S/G2 (EdU-positive)
EdU 5-ethynyl-2′-deoxyuridine, hDF human dermal fibroblast
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(both γH2AX and 53BP1) after treatment with 1 Gy was
higher in the cells in G1 phase than in those in S/G2
phase (Fig. 4b). Taken together, this set of data reveals that
a high level of spontaneous DNA damage (replicative
stress occurring in S/G2 phase) dramatically distorts the
outcome of γ-irradiation as measured by the numbers of
γH2AX and 53BP1 foci.
As detailed above, we have found that irradiated high-
passage hiPSCs load their DNA with much lower amounts
of γH2AX and 53BP1 than irradiated hDFs and low-
passage hiPSCs, suggesting that high-passage hiPSCs are
somewhat less proficient at initiating DNA repair. Tofurther examine this issue, we also determined the num-
bers of γH2AX and 53BP1 foci at 2 and 6 h after γ-
irradiation and then analysed the shapes of the resulting
time-course curves. The steepness of the resulting curves,
which are shown in Fig. 5a and b, collectively confirm our
initial notion. The curves representing hDFs and low-
passage hiPSCs decline more steeply, indicating a faster
decrease in DSBs, while the curves representing high-
passage hiPSCs decline more gradually, indicating slower
recovery from DSBs.
We also analysed hESCs in parallel to hiPSCs to deter-
mine whether the studied phenomena are associated with




Fig. 5 The time-course showing the recovery of human dermal fibroblasts (hDFs) and hiPSCs (a,b) or hESCs (c,d) after 1 Gy of γ-irradiation. a,c
Number of DSBs recognized by γH2AX and b,d by p53-binding protein 1 (53BP1) in the untreated control (0 h) and at 0.5 h, 2 h, and 6 h after
irradiation with 1 Gy. The results are shown in the EdU-negative population. The mean value of the DSBs was calculated for each of the three
regions on the slide. The error bar indicates the SEM
Simara et al. Stem Cell Research & Therapy  (2017) 8:73 Page 9 of 13per se. Overall, the differences between irradiated low-
and high-passage hESCs were much less pronounced
than those in hiPSCs. This conclusion is substantiated
by the numbers of: 1) γH2AX foci in low- and high-
passage EdU-negative hESCs (21.0 versus 16.3); 2)
53BP1 foci in low- and high-passage EdU-negative
hESCs (16.8 versus 21.5) (Fig. 3c and d); 3) γH2AX
foci in low- and high-passage EdU-positive hESCs
(30.4 versus 19.4); and 4) 53BP1 foci in low- and
high-passage EdU-positive hESCs (19.1 versus 24.2)
(Fig. 4a). It is of note that in high-passage hESCs
(both EdU-negative and EdU-positive) the numbers of
53BP1 foci (but not of γH2AX foci) even increased
compared to those typical for low-passage hESCs.
Finally, the steepness of the time-course curves indi-
cated that the decrease was more similar to hDFs
than to hiPSCs (Fig. 5c and d).
To test possible differences in the sensitivity of par-
ticular cell types to apoptotic signals, we investigated
the cleavage of PARP, an indirect marker of DNA
damage, and early apoptosis using Annexin-V/7-AAD
assay. A Western blotting analysis of PARP in hiPSC
lines demonstrated that the highest cleavage occurred
at 2 h after γ-irradiation (Fig. 6a and b). No differ-
ence was observed between low and high passages.
The PARP cleavage was later accompanied by a de-
crease in cell viability at the 6-h time-point in all
hiPSC lines with the exception of high-passage CBIA-
5 cells. Interestingly, hDFs and hESCs did not display
as much sensitivity to 1 Gy γ-irradiation as hiPSCs
(Fig. 6c).Discussion
A DNA molecule is unstable and subject to internal
and external harmful factors. Correct functioning of the
DNA repair mechanisms is, therefore, essential for the
maintenance of genomic integrity. In the field of hiPSC
research, only cells with an intact genome can be used
for clinical application. Unfortunately, the generation
and expansion of hiPSCs in vitro causes genomic in-
stability. In our research, we monitored the amount of
DSBs, either spontaneous or irradiation-induced, in
three lines of hiPSCs (CBIA-3, CBIA-5, and CBIA-7) at
low or high passage numbers, as well as in original
source cell fibroblasts (hDFs). One hESC line (CCTL-
14) was also examined. Our goal was to shed light on
the reaction of the cells to reprogramming and on the
prolonged in vitro culturing of pluripotent cells. Here,
we focused specifically on the kinetics of DSB gener-
ation and repair, cell cycle speed changes, triggering of
apoptosis, and cell viability. Special attention was paid
to the cell cycle phase of individual cells.
We selected two markers of DSBs—the phosphory-
lated histone variant γH2AX and its binding partner, the
DNA repair mediator 53BP1. Fluorescence microscopy
was chosen to detect these proteins because it offers two
main advantages over other methods such as Western
blotting. First, the expression of 53BP1 does not change;
only its localization at DNA damage sites is affected.
Second, analysis at the single-cell level assures a higher
sensitivity and allows for the discrimination between
cells at various cell cycle phases. We employed EdU
staining, which discriminates between the G1 and S/G2
ba
c
Fig. 6 PARP expression and early apoptosis. Cells were exposed to 1 Gy radiation and analysed by Western blotting and flow cytometry after 0.5,
2, and 6 h. a Western blotting of PARP, cleaved PARP (c-PARP), and GAPDH. b Densitometric analysis shows the ratio of cleaved PARP to uncleaved
PARP. c Annexin-V and 7-AAD were measured to assess the level of early apoptosis by flow cytometry. The Annexin-V- and 7-AAD-negative cell
population is shown in the graph (± SEM). *P ˂ 0.05 versus control (Ctrl) within each group by one-way ANOVA and Tukey’s multiple comparison test).
hDF human dermal fibroblast
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analogue of thymidine (EdU) into the DNA during repli-
cation, only cells in the S or G2 stage are labelled posi-
tive [35]. The images were analysed using Acquiarium
software. This software allows us to reliably determine
the foci number together with the intensity of the EdU
signal for each individual cell and to analyse the data
from hundreds of cells per sample on a large scale. Our
method for separating EdU-negative (G1 phase) cells
from EdU-positive (S/G2 phase) cells is based on plot-
ting the EdU intensity levels in histograms and using the
Otsu method to find the threshold. Using this method,
we revealed a longer cell cycle in somatic cells compared
to pluripotent cells, which is in accordance with previously
published data [36–39] and justifies the use of this method
for cell cycle discrimination on the single-cell level. This
approach also assures consistency among samples.
While counting the numbers of γH2AX and 53BP1
foci, it is of utmost importance to know exactly which
phase of the cell cycle each individual cell is in at themoment. Our data show that cells in S/G2 phase contain
more γH2AX and 53BP1 foci than cells in G1 phase and
that this difference is more pronounced in non-
irradiated controls. These foci emerge due to replication
stress during S phase [12, 22, 23, 40]. The replication-
related foci play a critical role in the comparison of DSB
numbers, especially between different cell types. As long
as the cells have a similar cell-cycle length (e.g. pluripo-
tent cells at a similar passage number), the number of
DSBs could be compared relatively well without using
cell cycle discrimination. However, the following factors
influence the cell cycle speed and should be considered: 1)
pluripotent cells have been reported to have a shorter cell
cycle than differentiated somatic cells [36–39]; 2) pluripo-
tent cells at high passages may have an increased rate of
proliferation [39, 41, 42]; and 3) irradiation induces cell
cycle arrest through checkpoints [43–45]. We analysed
the foci number separately for the EdU-negative and EdU-
positive groups to eliminate the replication stress bias.
Our data indicate a higher percent increase of foci upon
Simara et al. Stem Cell Research & Therapy  (2017) 8:73 Page 11 of 13γ-irradiation of cells in G1 phase, which are not burdened
by replication-related foci. The cell-cycle dependency
was confirmed for both γH2AX and 53BP1 markers. In
general, fewer foci were detected for 53BP1 than for
γH2AX, suggesting that 53BP1 is a less sensitive DSB
marker with a lower capacity to recognize DSBs than
γH2AX. It is known that the HR pathway plays a piv-
otal role during hiPSC generation [46], and 53BP1 pro-
motes the NHEJ repair pathway while inhibiting the HR
pathway [19–21]. In contrast, γH2AX influences both
the NHEJ and HR pathways, and 53BP1 does not bind
to all of the γH2AX foci [10, 11, 18].
Similar research was performed by Suchánková et al.
[25], who measured the formation of γH2AX- and
53BP1-positive nuclear bodies in relation to cell cycle
stages. They used genetically modified HeLa-Fucci cells,
which are able to express RFP-Cdt1 in the G1 phase
and GFP-geminin in the S/G2/M phases to discriminate
among the cell cycle phases. They observed a higher
number of γH2AX-positive repair foci in the G2 phase
than in the G1 phase for both non-irradiated and γ-
irradiated (5 Gy) HeLa cells. In contrast to our work, they
did not observe such a difference for 53BP1. It is of note
that different cell types as well as a different radiation dose
(1 Gy) were used in our study compared to Suchankova
et al., and it has been previously published that foci forma-
tion upon ionizing radiation may vary between cell types
and is radiation-dose dependent [32, 34, 47, 48].
In our study, we worked with three unique hiPSC
lines that were derived from two independent cell types
(dermal fibroblasts and blood cells) and reprogrammed
either by the Sendai virus or episomal vectors. This se-
lection of samples enables us to generalize our conclu-
sions for hiPSCs to a certain extent. To avoid bias
caused by replication-related foci, we further analysed
γH2AX and 53BP1 foci numbers only in the G1 (EdU-
negative) subgroup. Our results indicate that spontan-
eously occurring DSBs are best recognized by both
markers in hiPSCs at low passage, while fewer foci were
observed in hiPSCs at high passage and in source fibro-
blasts. A low foci number in fibroblasts, therefore, is in-
creased significantly after reprogramming into hiPSCs
(either by Sendai virus or episomal vectors) and then
decreases again after long-term in vitro passaging. Our
results are consistent with recently reported data show-
ing that H2AX plays a critical role in iPSC generation.
Gonzáles et al. reported an increase in γH2AX during
the cellular reprogramming of mouse embryonic fibro-
blasts independent of viral integration [46]. The HR
pathway was confirmed to be essential for the error-
free repair of DSBs in both genome-integrating and
non-integrating reprogramming. The importance of
H2AX at the early stage of reprogramming was also
suggested by Wu et al. [49]. Our observations markedlyresemble the results of copy number variation (CNV)
measurements by Hussein et al. [50]. They concluded
that most de novo-formed CNVs are present in early-
passage hiPSCs, while fewer CNVs are found in late-
passage hiPSCs and fibroblasts. There is a strong
connection between CNVs and DSBs because deletions
in subtelomeric regions have been shown to be highly
sensitive to DSBs and are the major cause of chromo-
somal instability [51, 52]. Similar results were published
by Laurent et al. [7] who reported a higher frequency of
CNVs in pluripotent samples than in non-pluripotent
samples and noticed that some of the deletions receded
from the population over long-term passaging. Taken
together, their data suggest that genomic instability is
highest in low-passage hiPSCs, and CNVs vanish during
multiple clonal-based passages because most of the
mutations do not provide any advantage. However,
certain growth-advantageous mutations—for example,
defects in genes controlling the cell cycle—may be fixed
in the population [5].
The abovementioned findings imply that more DSBs
at low passages are detected as a consequence of repro-
gramming stress and disappear as the hiPSCs are
adapted to in vitro conditions and clonally selected.
However, the irradiation experiments revealed that the
high-passage hiPSCs cannot recognize DSBs as effect-
ively as hDF source cells, particularly by γH2AX. The
lack of ability to recognize the irradiation-induced
DSBs was also obvious in all three high-passage hiPSCs
lines in the time-course study. These data suggest that
hiPSCs lose their repair capacity over multiple passages
in vitro. Similar results were published by Zhang et al.
on one mouse iPSC line [29]. They confirmed the com-
promised DNA damage repair capacity of iPSCs com-
pared with the respective source cells after γ-irradiation
treatment but did not focus on the length of the
in vitro culturing of iPSCs. For potential clinical appli-
cations, the length of in vitro culturing time should be
reduced to as short as possible. However, a certain
amount of time in vitro is unavoidable because of the
reprogramming process itself, cell expansion, and clear-
ance of the remaining reprogramming factors (viral
particles or vectors).
Of note, low- and high-passage hiPSCs displayed
similar apoptotic responses upon γ-irradiation. PARP
cleavage peaked 2 h after irradiation, which led to an
increase in early apoptosis after an additional 4 h in
most of the hiPSC lines. These data suggest that,
despite differences in DSB recognition, both low- and
high-passage hiPSCs exert DNA protection mecha-
nisms that trigger apoptosis in reaction to γ-irradiation.
Increased apoptosis was not observed in somatic hDFs
or in the hESC line CCTL-14, suggesting their lower
sensitivity to DNA damage.
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This study addresses the question of hiPSC capability to
repair their DNA using three independent lines of hiPSCs.
It shows for the first time that: 1) reprogramming to pluri-
potency increases the number of DNA double-strand
breaks (DSBs) as recognized by the γH2AX and 53BP1
proteins; 2) these DSBs are not due to replicative stress to
DNA; and 3) their numbers become reduced during
prolonged propagation after reprogramming. It also
shows that prolonged passaging of hiPSCs is associated
with a decrease in their DNA repair capacity and that
this is not the case for the hESC line CCTL-14. From a
technical point of view, this study documents that solid
accuracy in analysing numbers of DSBs requires discrim-
ination between the cells in G1 and S/G2 phases of their
cell cycle. Collectively, hiPSCs at low passage contain
more DSBs than hiPSCs at high passage, but they can re-
pair them more efficiently.Additional files
Additional file 1: Figure S1. Immunocytochemistry of pluripotency
markers. The pluripotency markers Oct-3/4, Sox2, Nanog, and SSEA4 are
highly expressed in all three hiPSC lines used in this study (CBIA-3, CBIA-
5, and CBIA-7). An anti-mouse secondary antibody conjugated with Alexa
Fluor® 488 was used to detect Oct-3/4, Sox2, and SSEA4. An anti-rabbit
secondary antibody conjugated with Alexa Fluor® 488 was used to detect
Nanog. Scale bar = 100 μm. (PPTX 384 kb)
Additional file 2: Figure S2. Histological staining of a teratoma. Cell
types representative of the three germ layers were detected by histological
analysis in the CBIA-7 hiPSC cell line at passage number 26. (A) Glandular
structures with secretory cells (endoderm); (B) mesenchymal cells
(mesoderm); (C) cells with melanin (ectoderm); (D) glomerulus-like
cells (mesoderm). (PPTX 32103 kb)
Additional file 3: Figure S3. Histograms of EdU signal intensity. The
distribution of the EdU-negative and EdU-positive populations in hDF
source cells, hiPSCs (CBIA-3, CBIA-5, and CBIA-7) and hESCs (CCTL-14) at
low or high passage is shown. The samples were fixed 0.5 h, 2 h, and 6 h
after 1 Gy of γ-irradiation. The thresholds for the EdU-negative population
were calculated as described in the Methods section and are marked
with a dotted line. (PPTX 251 kb)Abbreviations
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